Growth Metrics

Dexcom (DXCM) Gross Margin (2010 - 2026)

Dexcom (DXCM) reported Gross Margin of 62.95% for Q1 2026, up 610.0% year-over-year from 8.87% in Q1 2025, and little changed on a QoQ basis from 62.93% in Q4 2025.

Dexcom (DXCM) has 17 years of Gross Margin data on file, last reported at 62.95% in Q1 2026.

  • Quarterly Gross Margin rose 610.0% year-over-year to 62.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61.5% (up 207.0% YoY) and the FY2025 annual result came in at 60.1%, down 36.0% from the prior year.
  • Gross Margin steadied at 62.95% in Q1 2026 per DXCM's latest filing, from 62.93% in the prior quarter.
  • Across five years, Gross Margin topped out at 66.4% in Q4 2022 and bottomed at 56.85% in Q1 2025.
  • The 5-year median for Gross Margin is 62.71% (2023), against an average of 62.1%.
  • The widest annual swing landed in 2022, when Gross Margin tumbled 552 bps; it then surged 610 bps in 2026.
  • Tracing DXCM's Gross Margin over 5 years: stood at 66.4% in 2022, then slipped by 4 bps to 63.47% in 2023, then declined by 7 bps to 58.9% in 2024, then grew by 7 bps to 62.93% in 2025, then gained by 0 bps to 62.95% in 2026.
  • Per Business Quant, the three latest DXCM Gross Margin figures stand at 62.95% (Q1 2026), 62.93% (Q4 2025), and 60.48% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 72.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 62.95%
Dec 31, 2025 62.93%
Sep 30, 2025 60.48%
Jun 30, 2025 59.53%
Mar 31, 2025 56.85%
Dec 31, 2024 58.90%
Sep 30, 2024 59.73%
Jun 30, 2024 62.40%
Mar 31, 2024 61.01%
Dec 31, 2023 63.47%
Sep 30, 2023 63.93%
Jun 30, 2023 62.71%
Mar 31, 2023 62.39%
Dec 31, 2022 66.40%
Sep 30, 2022 64.22%
Jun 30, 2022 64.56%
Mar 31, 2022 63.31%
Dec 31, 2021 67.69%
Sep 30, 2021 68.73%
Jun 30, 2021 70.09%
Mar 31, 2021 68.10%
Dec 31, 2020 70.15%
Sep 30, 2020 67.96%
Jun 30, 2020 62.88%
Mar 31, 2020 63.32%
Dec 31, 2019 66.83%
Sep 30, 2019 62.30%
Jun 30, 2019 61.39%
Mar 31, 2019 60.18%
Dec 31, 2018 65.92%
Sep 30, 2018 63.22%
Jun 30, 2018 63.34%
Mar 31, 2018 64.48%
Dec 31, 2017 69.46%
Sep 30, 2017 68.80%
Jun 30, 2017 68.87%
Mar 31, 2017 66.13%
Dec 31, 2016 68.17%
Sep 30, 2016 68.03%
Jun 30, 2016 62.27%
Mar 31, 2016 64.63%
Dec 31, 2015 69.72%
Sep 30, 2015 71.69%
Jun 30, 2015 70.82%
Mar 31, 2015 63.87%
Dec 31, 2014 68.75%
Sep 30, 2014 68.41%
Jun 30, 2014 68.56%
Mar 31, 2014 63.27%
Dec 31, 2013 65.96%
Sep 30, 2013 64.34%
Jun 30, 2013 61.69%
Mar 31, 2013 55.74%
Dec 31, 2012 52.55%
Sep 30, 2012 36.36%
Jun 30, 2012 47.66%
Mar 31, 2012 46.77%
Dec 31, 2011 47.77%
Sep 30, 2011 44.81%
Jun 30, 2011 55.61%
Mar 31, 2011 35.92%
Dec 31, 2010 44.70%
Sep 30, 2010 29.80%
Jun 30, 2010 38.34%